Literature DB >> 14132910

THE AETIOLOGY AND TREATMENT OF URINARY CALCULUS.

A HODGKINSON.   

Abstract

Keywords:  CALCIUM; CITRATES; OXALATES; PHOSPHATES; URINARY CALCULI; URINE

Mesh:

Substances:

Year:  1964        PMID: 14132910      PMCID: PMC2482712          DOI: 10.1136/pgmj.40.461.130

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  22 in total

1.  Present concepts concerning the origin of matrix and stones.

Authors:  W H BOYCE; J S KING
Journal:  Ann N Y Acad Sci       Date:  1963-03-05       Impact factor: 5.691

2.  Crystallographic analysis of urinary calculi: a 23-year survey study.

Authors:  E L PRIEN
Journal:  J Urol       Date:  1963-06       Impact factor: 7.450

3.  Idiopathic hypercaicuria.

Authors:  P H HENNEMAN; P H BENEDICT; A P FORBES; H R DUDLEY
Journal:  N Engl J Med       Date:  1958-10-23       Impact factor: 91.245

4.  Oxalosis.

Authors:  V F MARSHALL; M HORWITH
Journal:  J Urol       Date:  1959-09       Impact factor: 7.450

5.  [Not Available].

Authors:  J COTTET; C VITTU
Journal:  Presse Med       Date:  1955-06-08       Impact factor: 1.228

6.  Unfavorable results of acetylsalicylic acid in the treatment of recurrent urolithiasis.

Authors:  M ABRAMS
Journal:  J Urol       Date:  1957-03       Impact factor: 7.450

7.  The aetiology of primary hyperoxaluria.

Authors:  H E ARCHER; A E DORMER; E F SCOWEN; R W WATTS
Journal:  Br Med J       Date:  1958-01-25

8.  The use of aluminium hydroxide to prevent recurrent renal calculi.

Authors:  L N PYRAH; F P RAPER; I B SMITH
Journal:  Br J Urol       Date:  1956-09

9.  Experimental urolithiasis. X. On the state of calcium in the urine.

Authors:  C W VERMEULEN; G H MILLER; W H CHAPMAN
Journal:  J Urol       Date:  1956-04       Impact factor: 7.450

10.  The surface chemistry of bone. III. Observations on the role of phosphatase.

Authors:  W F NEUMAN; V DISTEFANO; B J MULRYAN
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.